Approval · Notice of Compliance 20379 · 2018
BMD SOLUBLE: Notice of Compliance 20379
Issued January 22, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20379
- Date
- January 22, 2018
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change to prescription status. labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BMD SOLUBLE | 02328135 | Dormant |
Medicinal ingredients
- BACITRACIN METHYLENE DISALICYLATE 440 MG per G